pharmacie et médicaments – Accès aux traitements contre les myélomes multiples

This written question asks about ensuring access to treatments for multiple myeloma, a type of blood cancer. It highlights concerns regarding the availability and affordability of these vital therapies for patients. The question seeks to understand the government's strategy to guarantee that all patients needing these treatments can receive them without undue barriers, potentially impacting healthcare providers and pharmaceutical companies.